New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity

Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be use…

Mar 21^st • 16 mins listen

Industry Challenges Contribute to Financial Toxicity

In this third panel discussion from ONS’s Health Policy Summit in Washington DC, Alan Balch, PhD, Patient Advocate Foundation chief executive officer, Mike Ybarra, MD, FAAEM, FACEP, vice president of medical affairs for the Pharmaceutical Research Manufacturers Association, and Jeannine…

Feb 18^th • 66 mins listen

Expanding the Reach of TIL Therapy: What Will it Take?

City of Hope, Academic Research, melanoma

Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.

Aug 4^th • 38 mins listen

New Guidelines for Managing Immunotherapy-Related Adverse Events

ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…

Feb 19^th • 13 mins listen